secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bolt Biotherapeutics, Inc. (BOLT)
CIK:        0001641281
Form:       8-K
Filed at:   2025-06-06T23:59:59+00:00
Accession:  0000950170-25-083180
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bolt Biotherapeutics effects 1-for-20 reverse stock split
---------------------------------------------------------

- Reverse stock split at 1-for-20 ratio effective June 6, 2025.
- Common stock begins trading on split-adjusted basis June 9, 2025 on Nasdaq under ticker BOLT.
- New CUSIP number is 097702203; par value unchanged at $0.00001 per share.
- No fractional shares issued; cash payment in lieu of fractional shares.
- Proportionate adjustments to outstanding stock options, equity plans, and warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641281/000095017025083180/0000950170-25-083180-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641281/000095017025083180/bolt-20250606.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-083180

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer